Skip to main content
. 2016 Jul 11;7(33):53392–53413. doi: 10.18632/oncotarget.10534

Figure 7. Stratification of patients on the basis of the seven-miRNA signature and recurrence.

Figure 7

The 300 GBM patients within this study were classified by the risk score defined in this study and divided into groups with and without recurrence in short times. The median time to recurrence from TCGA samples is 7 months.